[Treatment of depression: the current state and perspectives of the development of pharmacological studies].

A review of literature over the last two decades is presented. It is emphasized that psyachopharmacotherapy currently remains a main method of treatment of severe and moderate depression. Pharmacogenetic studies are directed mainly towards the identification of probable targets based on pharmacokinetcs and pharmacodynamics of andidepressants as well as the aspect of identification of probably predictors for treatment response.

[The development of management of clinical laboratory].

The implementation of monitoring of main indicators of activities of the centralized laboratory developed in the counseling diagnostic center N1 makes it possible to assess the effectiveness of its functioning with the view of development of management.